The Arora Report

Rss Facebook Twitter Linkedin

Stock Market News To Give You An Edge

Proven Track Record of Most Accurate Analysis

Stock Market News
To Give You An Edge​

Proven Track Record
of Most Accurate Analysis

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

COMPLETELY INDEPENDENT AND OBJECTIVE

The Arora Report, Ltd. is a rare publisher that does not accept advertisements. This way The Arora Report can not be influenced. The Arora Report also does not accept payments from any company that is the subject of the posts. The Arora Report has forsaken millions of dollars in revenues to avoid conflicts of interest. Our sole job is to help you. Read more.

TAKE PROFITS ON ZSCALER AND EXIT THE POSITION $ZS

March 28, 2018

This post was just published on ZYX Buy Change Alert. Take profits on ZS by scaling out in the zone of $27 to $32.43 and exit the position.  The reason for the wide zone is that the stock can trade in a wide zone. As a reminder, while scaling out, move the stops into the zone of $26.43 to $26.73. The stock is trading at $27.75 as of this writing. A knowledgeable investor would have turned $100,000 into over $1,000,000 with the help from The Arora Report. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF

Read More »

THREE NUMBERS SHOW THAT A TRADE WAR IS LESS LIKELY $BA $CAT $FB $AAPL $AMZN $GOOG $JPM $BAC $MU $SPY $QQQ $IWM

March 26, 2018

Three numbers show that a potential trade war between the U.S. and China, and possibly other countries, is less likely. Improving money flows are confirming that, at least temporarily. Let’s explore with two charts. Two charts Please click here for the previously published, annotated chart of the stock market. For full transparency, this chart is unchanged. Please click here for a similar chart for the subsequent period. The VUD indicator shown on the chart is akin to an X-ray of the market. The chart is of S&P 500 futures ESM8.  Similar conclusions can be drawn from popular ETFs such as

Read More »

WEEKLY MARKET DIGEST: STOCK MARKET X-RAY, CHINA SUPPORTS ITS STOCK MARKET, GOLD ROCKETS $DIA $GLD $QQQ $SLV $SPY $TBT $USO

March 25, 2018

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.  Please scroll down for the section What To Do Now. STOCK MARKET X-RAY, TRUMP THINKS OF A VETO AND CHINA SUPPORTS ITS STOCK MARKET March 23, 2018 To gain an edge, this is what you need

Read More »

STOCK MARKET X-RAY AND WHAT TO DO WITH MICRON $MU $LRCX $WDC

March 23, 2018

This post was just published on ZYX Buy Change Alert. To see the stock market x-ray, please click here. Micron (MU) is long from $21.77.  Micron stock is trading at $56 as of this writing.  The company reported earnings in line with consensus but less than the whisper numbers. Broadly speaking, the company produces two kinds of memory,  DRAM and NAND.  There are serious concerns about NAND pricing going forward. Investors that want to keep close track of MU may consider watching WDC and LRCX.  The reason for watching LRCX is that it provides equipment to manufacture NAND. The reason for watching WDC is

Read More »

PAY ATTENTION TO THE X-RAY RESULTS OF THE STOCK MARKET $MU $BA $CAT $JPM $BAC $FB $AAPL $AMZN $SPY $QQQ $GOOG $ASHR $FXI $IWM

March 23, 2018

To understand a patient’s condition, a doctor may order an X-ray and other tests. An X-ray provides the doctor with information that would otherwise be difficult to accurately glean. Given the volatility in the stock market, should investors be looking at the X-ray results of the market? If you answered “yes,” take a look at this chart. The VUD indicator shown on the chart is akin to an X-ray of the market. The chart is of S&P 500 futures ESM8,  Similar conclusions can be drawn from popular ETFs such as S&P 500 ETF SPY,  Nasdaq 100 ETF QQQ,  and small-cap

Read More »

TAKE PARTIAL PROFITS ON DROPBOX $DBX

March 23, 2018

This post was just published on ZYX Buy Change Alert. DBX is long from $21.  Early indication is for DBX to open around $28.  Consider taking profits on a 15% tranche at the open.  Here are the profit taking zones for more tranches. 15% at $32. to $34.50 25% at $36 to $39.50 25% at $39.75 to $41.50 There is no target on the remaining 20% at this time. Here are the stop zones. On a 20% tranche $26 to $26.43. 20% at $25 to $25.43 30% at $24 to $24.43 30% at $23 to $23.43   A knowledgeable investor would have

Read More »

OPPORTUNITY AND PERIL IN TESLA WHAC-A-MOLE AHEAD $TSLA $FB $AMZN $AAPL $NFLX $GOOG $GOOGL

March 20, 2018

Opportunity and peril in Tesla’s stock are ahead. Let’s explore the issue with a chart. Chart Please click here for an annotated chart of Tesla TSLA  stock. Please observe the following from the chart: • The chart shows a key psychological level of $300 drawn in white. • The chart shows a support zone drawn in yellow around the key psychological level. • The chart shows Tesla Whac-a-Mole. Lately when there is bad news for Tesla, buyers step in around $300, often driving the stock higher. In the past month, investors drove the stock to $357. • The chart shows

Read More »

ARENA: GOOD TRIAL RESULTS FROM THIS BIOTECH, OVER 400% GAIN POSSIBLE IN A BUYOUT $ARNA

March 20, 2018

This post was just published on ZYX Buy Change Alert.  Arena stock (ARNA) is long from $16.20.  ARNA is trading at $40.75 as of this writing, up $9.86 for the day.  It has traded as high as $44.44. The company reported impressive results from a Phase II trial of its ulcerative colitis drug. Previously we have stated that in a buyout, In the event of a buyout, a price in the zone of $44 to $52 is possible. Based on the trial results, we are revising the target zone in a buyout to $75 to $88. The new buy zone for Arena is $28 to

Read More »

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

AI is power hungry. Investors will make a fortune from nuclear power for AI.

Get the list of 12 nuclear power stocks to grab your share of the profits.

Big Tech is investing billions

Making A Fortune
In Nuclear Energy

Golden Age of Nuclear Energy

Skip to content